A Randomized, Double Blind Phase 3 Study of Ibrutinib in

Project: Research project

Project Details

Description

A Randomized, Double Blind Phase 3 Study of Ibrutinib in Combination with Corticosteroids vs Placebo in Combination with Corticosteroids in Subjects with New Onset Chronic Graft vs Host Disease (cGVHD)
StatusActive
Effective start/end date11/1/1611/30/22

Funding

  • PHARMACYCLICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.